Yue Xiang

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Center for Drug Evaluation and Research(Current)

Yue Xiang is an author at Center for Drug Evaluation and Research specializing in oncology pharmacotherapy, malignant neoplasms, and combination cancer therapy.

ORCID

Publications per year

2023–2024

Publications

FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma

Timil H. Patel, Jamie R. Brewer, Jiaxin Fan et al. · Clinical Cancer Research · 2023 · 63 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

An Explanation of Why Dose-Corrected Area Under the Curve for Alternate Administration Routes Can Be Greater than for Intravenous Dosing

Hirokazu Wakuda, Yue Xiang, Jasleen K. Sodhi et al. · The AAPS Journal · 2024 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–2 of 2